
This rare, chronic autoimmune disease can cause kidney failure if left untreated

Medscape Education receives National Scleroderma Foundation’s Rocky Mountain Chapter's “Partner of Hope Award” for empowering the patient voice and shortening the diagnostic journey. This recognition honors Medscape Education’s significant commitment...

The Krascendo 1 study showed improved survival rates of 18 months compared to 12 months with current standard of care

If approved, this treatment would offer a new option for the nearly one million Americans living with MS

The two companies aim to discover and develop novel bispecific antibodies for immunology and inflammation diseases

MOGAD, a rare disease of the central nervous system, can attack optic nerves, the spinal cord and the brain

This is the first oral drug treatment for this rare disease in adults

67,000 new cases of pancreatic cancer are diagnosed in the US each year

This is the first and only at-home subcutaneous treatment option for this disease

Over one million people are diagnosed globally each year and around 30% of stage 3 patients relapse within five years

The companies will co-develop and co-commercialise bexobrutideg across malignant haematology, immunology and neurology

The treatment can be used to delay the onset of clinical type 1 diabetes